Introduction: Sleep disorders, especially insomnia, are very common in different kinds of
cancers, but their prevalence and incidence are not well-known. Disturbed sleep in cancer is …

Introduction Neo/adjuvant therapy for early-stage breast cancer has become increasingly
common in the last few decades; as a consequence, the number of breast cancer survivors …

Sleep disturbance is one of the most common and troubling symptoms that harm the quality
of life throughout all phases of treatment and stages of the illness among patients with …

BACKGROUND Premenopausal women diagnosed with breast cancer are at risk for
psychological and behavioral disturbances after cancer treatment. Targeted interventions …

Insomnia is highly prevalent among patients with breast cancer (BC). Although cognitive
behavioral therapy for insomnia (CBT-I) is available in integrative oncology settings, it poses …

Patients with advanced cancer who have pain that responds poorly to opioid therapy pose a
clinical challenge. Nabiximols (Nabiximols is the US Adopted Name [USAN] for Sativex [GW …

Purpose Fatigue, depression, and sleep disturbance are common adverse effects of cancer
treatment and frequently co-occur. However, the possibility that inflammatory processes may …

OBJECTIVE: The pain, depression, and fatigue symptom cluster is an important health
concern. Loneliness is a common risk factor for these symptoms. Little is known about the …

Purpose Sleep disturbance and cancer-related fatigue (CRF) are among the most commonly
reported symptoms associated with breast cancer and its treatment. This study identified …

Surgery remains a cornerstone of oncology treatment, and minimally invasive approaches,
enhanced recovery pathways (ERPs), and other interventions have improved safety and …